from Wiktionary, Creative Commons Attribution/Share-Alike License

  • n. A particular oral drug used to treat cancer.


Sorry, no etymologies found.


  • Most importantly, she played an active role in the discovery of the dual erbB2/EGFR tyrosine kinase inhibitor, lapatinib, which is currently marketed as Tykerb®.

    RedOrbit News - Technology

  • In a statement, the National Institute for Health and Clinical Excellence said that lapatinib, sold as Tyverb by GlaxoSmithKline PLC, is not cost-effective.

    UK Recommends Against Buying Breast Cancer Drug

  • Tyverb, known generically as lapatinib, treats breast-cancer patients who have tested positive for a protein called HER2.

    U.K. Advisers

  • Tyverb, sold as Tykerb in the U.S. and known generically as lapatinib, had modest world-wide sales of £51 million last year, its first year on the market.

    Glaxo Drug Hits U.K. Insurance Hurdle

  • It could be hormonal, chemo or biological — herceptin or lapatinib — depending on the tumor type and the woman's symptoms.

    What Elizabeth Edwards Can Expect

  • Recent positive data for GlaxoSmithKline's lapatinib, combined with Genentech's breast cancer drug Herceptin, builds on the latter's proven efficacy.

    Cancer Combos

  • Sir Andrew Dillon, Chief Executive of Nice said: Having reviewed the available evidence, our committee of experts has found that while both lapatinib and trastuzumab can reduce the growth and further spread of metastatic breast cancer tumours when taken alongside the aromatase inhibitors letrozole and anastrozole, the extent that these treatments can improve overall survival appears to be small or undefined. - Telegraph online, Daily Telegraph, Sunday Telegraph

  • The two drugs are Tykerb (lapatinib) and Herceptin (trastuzumab).

    Yahoo! News: Business - Opinion

  • The CHMP has recommended conditional approval for GSK's Votrient (pazopanib) for the treatment of advanced renal cell carcinoma and also backed extended use of the firm's breast cancer drug Tyverb (lapatinib).

    PharmaTimes World News

  • Use of the molecularly targeted agent lapatinib to delay tumor growth and improve the survival of pa ...



Log in or sign up to get involved in the conversation. It's quick and easy.